| 英文名 | 3-Fluoro-4-{[hydroxy(5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-2-nap hthalenyl)acetyl]amino}benzoic acid |
|---|---|
| 英文别名 |
3-FLUORO-4-[(R)-2-HYDROXY-2-(5,5,8,8-TETRAMETHYL-5,6,7,8-TETRAHYDRO-NAPHTHALEN-2-YL)-ACETYLAMINO]-BENZOIC ACID
(R)-3-Fluoro-4-(2-hydroxy-2-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)acetamido)b 3-Fluoro-4-[[2-hydroxy-2-(5,5,8,8-tetramethyl-5,6,7,8,-tetrahydro-2-naphthalenyl)acetyl]amino]-benzoic acid Benzoic acid, 3-fluoro-4-[[2-hydroxy-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)acetyl]amino] 3-FLUORO-4-[2-HYDROXY-2-(5,5,8,8-TETRAMETHYL-5,6,7,8-TETRAHYDRO-NAPHTHALEN-2-YL)-ACETYLAMINO]-BENZOIC ACID BENZOIC ACID, 3-FLUORO-4-[[(2R)-HYDROXY(5,6,7,8-TETRAHYDRO-5,5,8,8-TETRAMETHYL-2-NAPHTHALENYL)ACETYL]AMINO] |
| 描述 | BMS961是一种选择性维甲酸受体-γ(RARγ)激动剂。BMS961具有抗炎活性[1]。 |
|---|---|
| 相关类别 | |
| 靶点 |
RARγ |
| 体外研究 | BMS961抑制Dectin-1和促炎细胞因子的表达[1]。 |
| 参考文献 |
| 分子式 | C23H26FNO4 |
|---|---|
| 分子量 | 399.45500 |
| 精确质量 | 399.18500 |
| PSA | 90.12000 |
| LogP | 5.19450 |